Clinical Trial Update: A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating perioperative CV301 vaccination in combination with nivolumab and systemic chemotherapy for metastatic colorectal cancer has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CV301 (CV301 vaccine)
• nivolumab (nivolumab)

Snippet

Sponsor: Patrick Boland | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-07-22